Stock Rating Upgrade
Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Iovance Biotherapeutics Inc (NASDAQ: IOVA) rose significantly in recent days. IOVA’s current Value Trend Rating is C and the prior Rating was F. Details supporting this higher rating are included in our next report.
Recent Price Action
Iovance Biotherapeutics Inc (NASDAQ: IOVA) stock was unchanged 0.0% on 3/7/25. The shares closed at $3.75. Trading volume in this flat performance was normal. The stock has been extremely weak relative to the market over the last nine months and has declined -28.7% during the last week.
Current PriceTarget Research Rating
Iovance Biotherapeutics has a current Value Trend Rating of C (Neutral). This VT Rating rose significantly in recent days from F previously. This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Iovance Biotherapeutics has a very high Appreciation Score of 99 but a very low Power Rating of 2, resulting in the Neutral Value Trend Rating.
Be the first to comment